Search:

< Go Back

Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical Trials With Vortioxetine, An Investigational Compound For Major Depressive Disorder
New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy
CardioDx Announces New Data Demonstrating Use of Corus® CAD in the Primary Care Setting for Evaluation of Symptomatic Patients with Suspected CAD Influences Clinical Decision Making
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Boston Scientific Presents Clinical Data at Digestive Disease Week®
Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR
Eisai Highlights New Research On Melanoma, Breast and Endometrial Cancer at ASCO Annual Meeting
Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy
Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials
Andain Inc. Discusses and Provides Update on Its Breakthrough Wrinkle Treating Nano-Particles Booster and Delivery for Regenerating Skin Tissue
Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
Novelos Therapeutics Provides Product Pipeline Update
NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events
New Clinical Study Finds Masimo rainbow® Acoustic Monitoring™ Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients
Echo Therapeutics to Unveil Symphony® CGM System in Webcast
Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of Immunologists
DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO annual meeting
Helsinn Group and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data
Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
University Hospitals Case Medical Center Experts to Present Data at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) Addressing Patient and Physician Barriers to Clinical Trials
Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes
XBiotech Announces Results for its XILONIX™ Treatment of Non-Small Cell Lung Cancer (NSCLC)
First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Drainage In Patients With Pancreatic Or Periampullary Cancers
PCORI Opens Second Year of Research Funding with $81 Million in New Round of Announcements
Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases
ACell MatriStem® Technology Ranks Highest in Constructive Remodeling
FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T
New Roche Award for Antibody-based Cancer Therapy Research
Five UTEST companies to tackle critical healthcare challenges
2013 Marks 20th Anniversary of Landmark Clinical Research from Loma Linda University
Kinesia ProView Launches to Visualize Parkinson's Symptom Response to Deep Brain Stimulation Programming
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting

< Prev Next >
PR Newswire - United Business Media